Lumateperone tosylate: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 April 2025

  • curprev 13:1713:17, 13 April 2025 Omid Afkhami-Ardakani talk contribs 4,573 bytes +4,573 Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=Lumateperone Tosylate​ |aOrAn=an |drugClass=Atypical Antipsychotic |indicationType=treatment |indication=schizophrenia and depressive episodes associated with bipolar I or II disorder (bipolar depression) in adults. |hasBlackBoxWarning=Yes |adverseReactions=Most common adverse reactions (≥5% and twice the rate of placebo): somnolence/sedation, dry mouth. |blackBoxWarningTitle=Increased Mortalit..."